Purdue Pharma filed for bankruptcy protection Sept. 15 as part of a strategy to protect itself and its owners from thousands of lawsuits alleging it helped fuel the U.S. opioid epidemic. 

Several commonly prescribed breast cancer drugs could lead to severe and even fatal lung issues, the FDA warned Sept. 13.

Steroids can be purchased easily through social media sites Facebook and Youtube, according to a new study by a coalition of nonprofits, including the Taylor Hooton Foundation and Digital Citizens Alliance.

An FDA advisory panel endorsed Sept. 13 the first protective therapy for peanut allergies, according to STAT.

A small strip mall pharmacy in Florida was the site of a $1.2 million health insurance fraud scheme, according to the Miami Herald.

Embattled OxyContin maker Purdue Pharma filed for bankruptcy on Sept. 15, according to The New York Times. 

The Drug Enforcement Administration is proposing to set more stringent limits on the amount of opioids the U.S. is allowed to produce, according to Drug Topics.

Implementing a pharmacist-led program for HIV pre-exposure prophylaxis treatment could improve patient satisfaction and pharmacist acceptability, according to a study from Oxford University cited by Pharmacy Times.

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are five reported by Becker's Hospital Review in the last two weeks:

Capsule Corp., a New York City-based online pharmacy startup, plans to expand to other large cities after raising $200 million, according to Bloomberg.

KRS Global Biotechnology, a Boca Raton, Fla.-based drug compounding facility, is recalling all lots of its unexpired human and animal drugs due to lack of sterility assurance.

Despite the new "right-to-try" law, many drugmakers still want a relevant regulatory authority to review requests from patients with life-threatening illnesses who want access to experimental drugs, according to a recent Government Accountability Office report.

Though several Big Pharma companies face a federal opioid trial next month, several have reached settlements that may allow them a sizable tax break, according to USA Today.

CVS Health agreed to pay $4.4 million to settle a lawsuit accusing it of exposing the HIV status of roughly 4,500 Ohio patients, according to The Columbus Dispatch. 

The owner of a New York City pharmacy has been charged with allegedly leading an opioid distribution ring and committing healthcare fraud, according to ABC 7.

The FDA is warning patients and healthcare providers that some ranitidine medicines, common heartburn drugs, contain a potentially cancer-causing impurity. 

The University of Washington School of Pharmacy in Seattle will partner with biopharmaceutical company UCB to improve patient access to epilepsy treatment and care, according to Medical Xpress. 

A new study released Sept. 11 explains why so many cancer drugs don't make it past clinical trials, according to STAT.

Ten hospitals and health systems that posted job listings seeking pharmacy leadership in the last week.

Sprout Pharmaceuticals has revoked its Sept. 4 news release claiming the FDA eased restrictions on its controversial female libido pill, according to STAT.